Our misson is to introduce 3D bioprinting of the bionic pancreas to clinical practice worldwide.
About us
POLBIONICA is a spin off from the Foundation of Research and Science Development, bringing to market the research developed in the BIONIC project. We are developing the first bionic pancreas suitable for transplantation, based on bioprinted 3D scaffolds, functional vessels and pancreatic islets. In the next step, it is planned to replace the pancreatic islets by stem cells transformed into alpha and beta cells.
PRODUCTS
POLBIONICA is bringing to market the key building blocks supporting the development of a bionic pancreas – a novel bioreactor, tailored bio-inks and 3D printing method
Diabetes in numbers
422 million
people worldwide suffer from diabetes.The World Health Organization estimates that by 2040 their number will increase to 640 million.
3 Million
people in Poland struggle with diabetes. About 200,000 patients diagnosed with type I diabetes.
1,6 Million
people died of diabetes. 2.2 million patients died as a result of diabetes complications associated with too high blood glucose levels.
Our Team
Meet our multidisciplinary team formed by higly qualified and creative scientists.
Our innovation is protected by European Patent EP19461559, covering a comprehensive procedure for preparing bionic pancreas, starting from the preparation of the ECM, which is the basis of produced bio-carcasses (bio-ink A and B) to the entire organ with the vascular system.